{"id":"W2990283038","doi":"10.1007/s12325-019-01145-8","title":"Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis","year":2019,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"AbbVie; Celgene; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Clinical trial; Rheumatology; Internal medicine; Term (time); Intensive care medicine; Safety profile; Adverse effect; Medical physics; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002236805,0.0001991912,0.001128287,0.0001248206,0.00003106881,0.00001153626,0.0001880723,0.0001683981,0.0003849814],"category_scores_gemma":[0.0003018862,0.0001539514,0.0002363691,0.000897383,0.000106,0.0004427963,0.00002486115,0.0001680272,0.00003040012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000131291,"about_ca_system_score_gemma":0.00006474359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004027177,"about_ca_topic_score_gemma":0.00341769,"domain_scores_codex":[0.9968888,0.0006879102,0.001391821,0.0004626949,0.0003135604,0.0002552488],"domain_scores_gemma":[0.9982425,0.0004739124,0.0005069241,0.0005354894,0.0001337671,0.0001074271],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003189655,0.001983686,0.904833,0.000005355905,0.000534596,0.00003416277,0.0005444164,0.00001633037,0.00003740304,0.00001545943,0.00000181807,0.0888041],"study_design_scores_gemma":[0.02566712,0.0006616728,0.9724441,0.00007230217,0.0001210708,0.000002424946,0.000187385,0.0001408891,0.0002864081,0.0001799596,0.0001044487,0.0001321846],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965062,0.001110686,0.0001298691,0.000115879,0.0002058324,0.001022915,0.0007787917,0.00002227835,0.000107576],"genre_scores_gemma":[0.9927573,0.003278556,0.000708535,0.00007699825,0.00004245587,0.00003843608,0.003063503,0.00001379187,0.00002046999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08867191,"threshold_uncertainty_score":0.6277954,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04198891975818134,"score_gpt":0.4470875412390481,"score_spread":0.4050986214808668,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}